-
Lilly Diabetes Becomes 'Official Diabetes Health Partner of NASCAR®'
lilly
March 06, 2017
NASCAR® and Lilly Diabetes announced today that Lilly is expanding its involvement in NASCAR with a multi-year official partnership with the sanctioning body.
-
MSD, Wayra unveil Velocity Health winners
pharmatimes
February 23, 2017
Merck Sharp & Dohme (MSD) and Wayra UK have unveiled the 2017 winners of Velocity Health, a ground-breaking preventative digital healthcare accelerator programme designed to address key care challenges.
-
Weight-Loss Surgery May Help Obese Patients Beat Diabetes
drugs.com
February 16, 2017
There's more evidence that obese patients with type 2 diabetes can control the disease better with weight-loss surgery, compared to medication alone.
-
Boehringer, Inovalon Enter Cloud Platform Pact
contractpharma
January 24, 2017
Aims to support greater customer insight, data integration and analytics
-
EU approval for c’s type 2 diabetes treatment
europeanpharmaceuticalreview
January 20, 2017
The European Commission (EC) has granted marketing authorisation in Europe for Sanofi‘s Suliqua, a titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 di
-
Study Ties Inflammation, Gut Bacteria to Type 1 Diabetes
drugs.com
January 20, 2017
People with type 1 diabetes show changes in their digestive system that aren't seen in people who don't have the autoimmune disease, a new Italian study finds.
-
Drugmakers partner to tackle non-communicable diseases in developing countries
firstwordpharma
January 19, 2017
More than 20 pharmaceutical companies on Wednesday launched a project termed Access Accelerated to tackle non-communicable diseases (NCDs) such as cancer and diabetes in low and lower-middle income countries.
-
Novo strikes up personalised diabetes treatment deal with Glooko
pharmafile
January 17, 2017
Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with a range of issues affecting patients with type 1 and 2 diabetes including treatment adherence and blood glucose management.